Pharma News

Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.

Ardelyx and Knight Collaborate to Bring Tenapanor to Patients in Canada

Tuesday, March 20, 2018

Ardelyx Inc announced a license agreement with Knight Therapeutics Inc Knight that provides Knight with exclusive rights to commercialize tenapanor in Canada Tenapanor is Ardelyx39s oral firstinclass small molecule treatment that has completed Phase 3 development for irritable bowel syndrome with co..

Mallinckrodt Completes Sale Of RECOTHROM® And PREVELEAK® To Baxter

Tuesday, March 20, 2018

Mallinckrodt plc a leading specialty pharmaceutical company announced today it has closed the sale of RECOTHROM Thrombin topical Recombinant and PREVELEAK Surgical Sealant to Baxter International Inc This action further illustrates the strategic evolution of our portfolio and will free resources ..

Intezyne Partners with Exosome Diagnostics on IT-139 Companion Diagnostic

Monday, March 19, 2018

Intezyne a clinicalstage biopharmaceutical company developing novel anticancer therapies announced that it has partnered with Exosome Diagnostics a privately held company focused on developing and commercializing revolutionary biofluidbased diagnostics to design and validate an assay for use in Inte..

Revolutionary DowDuPont Technology Available For The First Time Worldwide to Accelerate Discovery of Novel Protein Drugs

Monday, March 19, 2018

Proteins are the building blocks of science and the speed quality and efficiency of protein production research is being advanced through an agreement between Dow AgroSciences LLC and life sciences startup LenioBio Today the companies announce an exclusive license to enable LenioBio to utilize Dow A..

Lundbeck to acquire Prexton Therapeutics

Saturday, March 17, 2018

H Lundbeck AS Lundbeck and Prexton Therapeutics BV Prexton today announced signing of a definitive agreement in which Lundbeck will acquire Prexton Under terms of the agreement Lundbeck will pay EUR 100 million approximately DKK 750 million upfront and is furthermore required to later pay up to EUR ..

Ionis and Akcea Partner to Commercialize Inotersen for hATTR

Friday, March 16, 2018

Ionis Pharmaceuticals and Akcea Therapeutics Inc an affiliate of Ionis today announced an exclusive worldwide license by Ionis to Akcea for inotersen and AKCEATTRLRx formerly IONISTTRLRx in a transaction potentially worth up to approximately 17 billion to Ionis plus profit sharing payments This t..

Janssen Announces U.S. FDA Breakthrough Therapy Designation for Erdafitinib in the Treatment of Metastatic Urothelial Cancer

Friday, March 16, 2018

The Janssen Pharmaceutical Companies of Johnson Johnson announced today that the US Food and Drug Administration FDA has granted Breakthrough Therapy Designation for erdafitinib in the treatment of urothelial cancer Urothelial cancer most frequently in the bladder is the sixth most common type of c..

Propanc Biopharma Completes Successful Reproduction Run for PRP

Thursday, March 15, 2018

Propanc Biopharma Inc a clinical stage biopharmaceutical company focusing on development of new and proprietary treatments for cancer patients suffering from solid tumors such as pancreatic ovarian and colorectal cancers today announced the successful reproduction run of the manufacturing process fo..

OxThera Announces the Randomization of the First Patient Into its Phase III EPHEX Study With Oxabact

Thursday, March 15, 2018

OxThera AB a Stockholmbased privatelyheld biopharmaceutical company with a product in late stage clinical development focusing on Primary hyperoxaluria PH announces the randomization of the first patient into its phase III study EPHEX with Oxabact Study OC5DB02 EPHEX is a randomized placebocontr..

PAREXEL and CHA Medical Group Partner to Enhance Early Phase Clinical Research in Korea

Wednesday, March 14, 2018

PAREXEL International Corporation the worlds leading innovator of biopharmaceutical services today announced an alliance with CHA Medical Group CHA to enhance early phase clinical development in Korea The collaboration is designed to provide biopharmaceutical companies with comprehensive services th..